TFPI mAb treatment similarly decreased PB RBC numbers and Hb (supplemental Fig. 7H), and reduced F4/80+CD169+Vcam-1+ macrophage heme content in hypoxia-induced polycythemia mice (supplemental Fig. 7I). This evidence concerns the gene SIGLEC1 and polycythemia.